BridgeBio is significantly boosted the development of a new solution for cardiac amyloidosis, employing Attruby. Early clinical information reveals promising benefits for patients diagnosed with this serious condition. https://attrcm020584.digitollblog.com/42066876/company-improves-attr-cm-treatment-through-the-drug